|Salary:||£38,304 to £39,345 per annum, including London Weighting Allowance|
|Placed On:||11th June 2021|
|Closes:||1st July 2021|
This post is based at Guy’s Hospital, London Bridge and GRAIL’s office in central London but will be remote working until further notice.
The Cancer Research UK & King’s College London Cancer Prevention Trials Unit (CPTU) specialises in research to advance cancer prevention, early diagnosis and screening.
We perform research on efficacy, cost-effectiveness and technologies to improve existing and establish new screening programmes.
Our portfolio of both secondary (hospital) and primary (community) care trials includes:
We are looking for an enthusiastic trial monitor to join the CPTU team to be responsible for the monitoring activities for an exciting new early detection study.
You will be the trial monitor for a NHS research study of a multi-cancer early detection test with GRAIL Bio UK Ltd, NHS England and NHS Improvement. Over 700,000 people across England will be invited to receive a novel CE-marked, blood test for the presence of over 50 cancers. As well as being responsible for project-wide monitoring, you will also lead the set-up of monitoring processes including monitoring plans and report templates and contributing to delivering site initiation/training. This will be in close coordination with GRAIL Bio UK, CPTU Project and Trial Managers, and other key stakeholders.
You will have a strong interest in, and knowledge of clinical trials research, and prior monitoring experience, including on-site, remote and central monitoring within academia, the NHS or commercial health research sector. You will have excellent attention to detail and planning skills with an intrinsic interest in improving the health and well-being of communities through translational research and evidence-based innovation. The ability to communicate clearly, concisely, and professionally is essential.
This post is a Full-time 35 hours per week
This is a Fixed-term until 31 July 2024
Type / Role: